Study: Drug-involved overdose deaths increased by over 500% in 2022

Drug-involved overdose deaths increased by over 500 percent in 2022 according to a study at Columbia University Mailman School of Public Health, with trends attributed to synthetic opioids.

Ransomware attack shuts down hospital emergency rooms in several states

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in

August 8, 2023

Moderna cuts back on manufacturing; Lilly eyes Mounjaro supply boost; GSK’s shingles vaccine ‘unconstrained’

Endpoints News dug into this week’s earnings calls to gather biopharma manufacturing updates. We found that Moderna is cutting its manufacturing activities, while Amgen provided

November 3, 2023

Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset | Psychedelic Invest

VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development

April 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.